| Literature DB >> 28347700 |
Yeri Kim1, Joanne O Davidson2, Colin R Green1, Louise F B Nicholson3, Simon J O'Carroll3, Jie Zhang4.
Abstract
A common cause of mortality and long-term adult disability, cerebral ischemia or brain ischemia imposes a significant health and financial burden on communities worldwide. Cerebral ischemia is a condition that arises from a sudden loss of blood flow and consequent failure to meet the high metabolic demands of the brain. The lack of blood flow initiates a sequelae of cell death mechanisms, including the activation of the inflammatory pathway, which can ultimately result in irreversible brain tissue damage. In particular, Connexins and Pannexins are non-selective channels with a large pore that have shown to play time-dependent roles in the perpetuation of ischaemic injury. This review highlights the roles of Connexin and Pannexin channels in cell death mechanisms as a promising therapeutic target in cerebral ischemia, and in particular connexin hemichannels which may contribute most of the ATP release as a result of ischemia as well as during reperfusion. This article is part of a Special Issue entitled: Gap Junction Proteins edited by Jean Claude Herve.Entities:
Keywords: Blood brain barrier; Cerebral ischaemia; Connexin; Inflammation; Pannexin; Stroke
Mesh:
Substances:
Year: 2017 PMID: 28347700 DOI: 10.1016/j.bbamem.2017.03.018
Source DB: PubMed Journal: Biochim Biophys Acta Biomembr ISSN: 0005-2736 Impact factor: 3.747